Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Szarek; Szarek M.; White H.D.; M.; Alings M.; Bhatt D.L.; White; H.D.; Alings; Bhatt; D.L.; Andrejs Ērglis

doi:10.1016/j.jacc.2018.10.039

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Szarek
, Szarek M.
, White H.D.
, M.
, Alings M.
, Bhatt D.L.
, White
, H.D.
, Alings
, Bhatt
, D.L.
, Andrejs Ērglis

Research output: Contribution to journal › Article › peer-review

153 Citations (Scopus)

Original language	English
Pages (from-to)	387-396
Journal	Journal of the American College of Cardiology
Volume	73
Issue number	4
DOIs	https://doi.org/10.1016/j.jacc.2018.10.039
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jacc.2018.10.039

Cite this

@article{4e95a2acb7a649caa8fb0647119c6f8b,

title = "Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial",

author = "Szarek and Szarek M. and White H.D. and M. and Alings M. and Bhatt D.L. and White and H.D. and Alings and Bhatt and D.L. and Andrejs Ērglis",

year = "2019",

doi = "10.1016/j.jacc.2018.10.039",

language = "English",

volume = "73",

pages = "387--396",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

AU - Szarek, null

AU - M., Szarek

AU - H.D., White

AU - M., null

AU - M., Alings

AU - D.L., Bhatt

AU - White, null

AU - H.D., null

AU - Alings, null

AU - Bhatt, null

AU - D.L., null

AU - Ērglis, Andrejs

PY - 2019

Y1 - 2019

UR - https://www.sciencedirect.com/science/article/pii/S0735109718389617

U2 - 10.1016/j.jacc.2018.10.039

DO - 10.1016/j.jacc.2018.10.039

M3 - Article

SN - 0735-1097

VL - 73

SP - 387

EP - 396

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 4

ER -

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

UN SDGs

Access to Document

Other files and links

Cite this